Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


03.06.2024

1 Am J Surg Pathol
3 Ann Surg Oncol
1 BMC Cancer
1 Br J Cancer
4 Breast Cancer
1 Breast Cancer (Dove Med Press)
5 Breast Cancer Res
6 Breast Cancer Res Treat
2 Cancer Lett
1 Clin Breast Cancer
1 Clin Cancer Res
1 Eur J Cancer
2 Eur Radiol
1 J Biol Chem
3 J Clin Oncol
1 J Surg Oncol
1 JAMA
2 Mod Pathol
2 NPJ Breast Cancer
1 PLoS Genet
5 PLoS One
1 Radiol Artif Intell
1 Radiol Imaging Cancer
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. RETAMERO JA, Gulturk E, Bozkurt A, Liu S, et al
    Artificial Intelligence Helps Pathologists Increase Diagnostic Accuracy and Efficiency in the Detection of Breast Cancer Lymph Node Metastases.
    Am J Surg Pathol. 2024 May 29. doi: 10.1097/PAS.0000000000002248.
    PubMed         Abstract available


    Ann Surg Oncol

  2. SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
    Racial Disparities in Breast Cancer Genetic Testing May be Mitigated by Counseling.
    Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15434.
    PubMed         Abstract available

  3. SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
    ASO Visual Abstract: Racial Disparities in Breast Cancer Genetic Testing may be Mitigated by Counseling.
    Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15536.
    PubMed        


  4. The American Society of Breast Surgeons Official Proceedings, Volume XXV 2024 Annual Meeting Scientific Session Abstracts.
    Ann Surg Oncol. 2024;31.
    PubMed        


    BMC Cancer

  5. AZIZ MA, Chowdhury S, Jafrin S, Barek MA, et al
    Genetic association of Interleukin-17A polymorphism in Bangladeshi patients with breast and cervical cancer: a case-control study with functional analysis.
    BMC Cancer. 2024;24:660.
    PubMed         Abstract available


    Br J Cancer

  6. NG CW, Tsang YTM, Gershenson DM, Wong KK, et al
    The prognostic value of MEK pathway-associated estrogen receptor signaling activity for female cancers.
    Br J Cancer. 2024;130:1875-1884.
    PubMed         Abstract available


    Breast Cancer

  7. KATARIA M, Gupta N, Kumar A, Bhoriwal S, et al
    Assessing the effectiveness of high frequency repetitive transcranial magnetic stimulation for post-mastectomy pain in breast cancer patients: A randomized controlled trial.
    Breast Cancer. 2024 May 26. doi: 10.1007/s12282-024-01598.
    PubMed         Abstract available

  8. OKUYAMA H, Takada F, Taira N, Nakamura S, et al
    A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy.
    Breast Cancer. 2024 May 26. doi: 10.1007/s12282-024-01592.
    PubMed         Abstract available

  9. MUR-GIMENO E, Coll M, Yuguero-Ortiz A, Navarro M, et al
    Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial.
    Breast Cancer. 2024 May 30. doi: 10.1007/s12282-024-01596.
    PubMed         Abstract available

  10. TENG L, Du J, Yan S, Xu P, et al
    A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database.
    Breast Cancer. 2024 May 27. doi: 10.1007/s12282-024-01591.
    PubMed         Abstract available


    Breast Cancer (Dove Med Press)

  11. GU Q, Zhu M, Wang Y, Gu Y, et al
    Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab.
    Breast Cancer (Dove Med Press). 2024;16:253-268.
    PubMed         Abstract available


    Breast Cancer Res

  12. GLOTZBACH A, Rohlf K, Gonscharow A, Luke S, et al
    EDI3 knockdown in ER-HER2+ breast cancer cells reduces tumor burden and improves survival in two mouse models of experimental metastasis.
    Breast Cancer Res. 2024;26:87.
    PubMed         Abstract available

  13. RAGHURAM N, Temel EI, Kawamata T, Kozma KJ, et al
    Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation.
    Breast Cancer Res. 2024;26:86.
    PubMed         Abstract available

  14. JONES LI, Marshall A, Geach R, Elangovan P, et al
    Optimising the diagnostic accuracy of First post-contrAst SubtracTed breast MRI (FAST MRI) through interpretation-training: a multicentre e-learning study, mapping the learning curve of NHS Breast Screening Programme (NHSBSP) mammogram readers using a
    Breast Cancer Res. 2024;26:85.
    PubMed         Abstract available

  15. KUKLINSKI D, Blum M, Subelack J, Geissler A, et al
    Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.
    Breast Cancer Res. 2024;26:84.
    PubMed         Abstract available

  16. LIU C, Sun M, Arefan D, Zuley M, et al
    Deep learning of mammogram images to reduce unnecessary breast biopsies: a preliminary study.
    Breast Cancer Res. 2024;26:82.
    PubMed         Abstract available


    Breast Cancer Res Treat

  17. MENES TS, Zippel D, Sklair-Levy M, Friedman E, et al
    Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women.
    Breast Cancer Res Treat. 2024 May 26. doi: 10.1007/s10549-024-07345.
    PubMed         Abstract available

  18. ISOGAI A, Nozawa K, Nakakami A, Komaki R, et al
    Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study.
    Breast Cancer Res Treat. 2024 May 26. doi: 10.1007/s10549-024-07367.
    PubMed         Abstract available

  19. REWCASTLE E, Skaland I, Gudlaugsson E, Fykse SK, et al
    The Ki67 dilemma: investigating prognostic cut-offs and reproducibility for automated Ki67 scoring in breast cancer.
    Breast Cancer Res Treat. 2024 May 26. doi: 10.1007/s10549-024-07352.
    PubMed         Abstract available

  20. LUBARSKY M, Hernandez AE, Collie BL, Westrick AC, et al
    Does structural racism impact receipt of NCCN guideline-concordant breast cancer treatment?
    Breast Cancer Res Treat. 2024 May 29. doi: 10.1007/s10549-024-07245.
    PubMed         Abstract available

  21. VAN DER MERWE NC, Buccimazza I, Rossouw B, Araujo M, et al
    Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients.
    Breast Cancer Res Treat. 2024 May 30. doi: 10.1007/s10549-024-07362.
    PubMed         Abstract available

  22. ATRE SY, Soulos PR, Kuderer NM, Gross CP, et al
    Characterization of time toxicity in older patients with metastatic breast cancer.
    Breast Cancer Res Treat. 2024 May 31. doi: 10.1007/s10549-024-07379.
    PubMed         Abstract available


    Cancer Lett

  23. LIN Z, Chen L, Wang Y, Zhang T, et al
    Improving Ultrasound Diagnostic Precision for Breast Cancer and Adenosis with Modality-Specific Enhancement (MSE) - Breast Net.
    Cancer Lett. 2024 May 23:216977. doi: 10.1016/j.canlet.2024.216977.
    PubMed         Abstract available

  24. LV Y, Sun S, Zhang J, Wang C, et al
    Loss of RBM45 inhibits breast cancer progression by reducing the SUMOylation of IRF7 to promote IFNB1 transcription.
    Cancer Lett. 2024 May 24:216988. doi: 10.1016/j.canlet.2024.216988.
    PubMed         Abstract available


    Clin Breast Cancer

  25. KO G, Naganathan G, Reel E, Cleland J, et al
    The Impact of COVID-19 on Breast Cancer Care: A Qualitative Analysis of Surgeons' Perspectives.
    Clin Breast Cancer. 2024 Apr 25:S1526-8209(24)00111.
    PubMed         Abstract available


    Clin Cancer Res

  26. GOUGH SM, Flanagan JJ, Teh J, Andreoli M, et al
    Oral estrogen receptor PROTAC(R) vepdegestrant (ARV-471) is highly efficacious as monotherapy and in combination with CDK4/6 or PI3K/mTOR pathway inhibitors in preclinical ER+ breast cancer models.
    Clin Cancer Res. 2024 May 31. doi: 10.1158/1078-0432.CCR-23-3465.
    PubMed         Abstract available


    Eur J Cancer

  27. HAN W, Zhang DD, Zhang YW, Shi LZ, et al
    Letter re: Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: A systematic review and meta-analysis.
    Eur J Cancer. 2024 May 22:114126. doi: 10.1016/j.ejca.2024.114126.
    PubMed        


    Eur Radiol

  28. ZUIANI C, Mansutti I, Caronia G, Linda A, et al
    Added value of the EUSOBI diffusion levels in breast MRI.
    Eur Radiol. 2024;34:3352-3363.
    PubMed         Abstract available

  29. WANG L, Wang P, Shao H, Li J, et al
    Role of contrast-enhanced mammography in the preoperative detection of ductal carcinoma in situ of the breasts: a comparison with low-energy image and magnetic resonance imaging.
    Eur Radiol. 2024;34:3342-3351.
    PubMed         Abstract available


    J Biol Chem

  30. PANDEY A, Kakani P, Shukla S
    CTCF and BORIS-mediated Autophagy regulation via Alternative splicing of BNIP3L in Breast Cancer.
    J Biol Chem. 2024 May 27:107416. doi: 10.1016/j.jbc.2024.107416.
    PubMed         Abstract available


    J Clin Oncol

  31. SORSCHER S
    Omission of Radiotherapy for Women With Low-Risk Invasive Cancers That Have a Ductal Carcinoma In Situ Component.
    J Clin Oncol. 2024;42:1998.
    PubMed        

  32. RECHT A
    Internal Mammary Node Irradiation Debate: Case Closed? Not Yet, and Maybe Never.
    J Clin Oncol. 2024;42:1871-1874.
    PubMed         Abstract available

  33. AZIM HA JR, Niman SM, Partridge AH, Demeestere I, et al
    Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.
    J Clin Oncol. 2024 May 29:JCO2302292. doi: 10.1200/JCO.23.02292.
    PubMed         Abstract available


    J Surg Oncol

  34. DI PACE B, Padley RH
    Enhancing treatment compliance in breast cancer patients: A multi-faceted approach.
    J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27679.
    PubMed        


    JAMA

  35. MANSON JE, Crandall CJ, Rossouw JE, Chlebowski RT, et al
    The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
    JAMA. 2024;331:1748-1760.
    PubMed         Abstract available


    Mod Pathol

  36. AJABNOOR R, Zhang G, Hu Y, Gao Y, et al
    Breast Cancer with HER2 IHC 2+ and Average HER2 Signals/Cell >/= 6 and HER2/CEP17 Ratio < 2: A Multi-Institutional Cohort Analysis Emphasizing Outcome and Molecular Subtype.
    Mod Pathol. 2024 May 27:100530. doi: 10.1016/j.modpat.2024.100530.
    PubMed         Abstract available

  37. INGEBRIKTSEN LM, Svanoe AA, Saele AKM, Humlevik ROC, et al
    Age-related clusters and favorable immune phenotypes in breast cancer of the young.
    Mod Pathol. 2024 May 27:100529. doi: 10.1016/j.modpat.2024.100529.
    PubMed         Abstract available


    NPJ Breast Cancer

  38. POWELL RT, Rinkenbaugh AL, Guo L, Cai S, et al
    Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer.
    NPJ Breast Cancer. 2024;10:37.
    PubMed         Abstract available

  39. FU C, Duan S, Zhou X, Meng Y, et al
    Overexpression of COL11A1 confers tamoxifen resistance in breast cancer.
    NPJ Breast Cancer. 2024;10:38.
    PubMed         Abstract available


    PLoS Genet

  40. DENNIS M, Hurley A, Bray N, Cordero C, et al
    Her2 amplification, Rel-A, and Bach1 can influence APOBEC3A expression in breast cancer cells.
    PLoS Genet. 2024;20:e1011293.
    PubMed         Abstract available


    PLoS One

  41. FU Y, Zhou J, Li J
    Diagnostic performance of ultrasound-based artificial intelligence for predicting key molecular markers in breast cancer: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0303669.
    PubMed         Abstract available

  42. ALASMARI A
    Achillea fragrantissima (Forssk.) Sch.Bip instigates the ROS/FADD/c-PARP expression that triggers apoptosis in breast cancer cell (MCF-7).
    PLoS One. 2024;19:e0304072.
    PubMed         Abstract available

  43. ZHOU K, Robert M, Seegers V, Blanc-Lapierre A, et al
    Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
    PLoS One. 2024;19:e0304556.
    PubMed         Abstract available

  44. PRAMANIK P, Roy A, Cuevas E, Perez-Cisneros M, et al
    DAU-Net: Dual attention-aided U-Net for segmenting tumor in breast ultrasound images.
    PLoS One. 2024;19:e0303670.
    PubMed         Abstract available

  45. ELGHOROURY EA, Abdelghafar EE, Kamel S, Awadallah E, et al
    Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer.
    PLoS One. 2024;19:e0298536.
    PubMed         Abstract available


    Radiol Artif Intell

  46. PEDEMONTE S, Tsue T, Mombourquette B, Truong Vu YN, et al
    A Semiautonomous Deep Learning System to Reduce False-Positive Findings in Screening Mammography.
    Radiol Artif Intell. 2024 Apr 10:e230033. doi: 10.1148/ryai.230033.
    PubMed         Abstract available


    Radiol Imaging Cancer

  47. MITTAL S, Chung M
    Assessment of AI Risk Scores on Screening Mammograms Preceding Breast Cancer Diagnosis.
    Radiol Imaging Cancer. 2024;6:e249011.
    PubMed        


    Science

  48. HOULAHAN KE, Khan A, Greenwald NF, Vivas CS, et al
    Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity.
    Science. 2024;384:eadh8697.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.